Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BH.IMMUN&BIO vs ERIS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BH.IMMUN&BIO ERIS LIFESCIENCES BH.IMMUN&BIO/
ERIS LIFESCIENCES
 
P/E (TTM) x -5.9 51.1 - View Chart
P/BV x 1.2 7.3 15.9% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 BH.IMMUN&BIO   ERIS LIFESCIENCES
EQUITY SHARE DATA
    BH.IMMUN&BIO
Mar-23
ERIS LIFESCIENCES
Mar-24
BH.IMMUN&BIO/
ERIS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs52971 5.3%   
Low Rs21565 3.6%   
Sales per share (Unadj.) Rs10.3147.7 7.0%  
Earnings per share (Unadj.) Rs-3.929.2 -13.2%  
Cash flow per share (Unadj.) Rs-3.842.6 -8.9%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs20.4189.7 10.8%  
Shares outstanding (eoy) m43.18136.03 31.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.55.2 67.3%   
Avg P/E ratio x-9.426.3 -35.7%  
P/CF ratio (eoy) x-9.518.0 -52.7%  
Price / Book Value ratio x1.84.0 43.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,561104,470 1.5%   
No. of employees `000NANA-   
Total wages/salary Rs m1514,038 3.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m44620,091 2.2%  
Other income Rs m11238 4.5%   
Total revenues Rs m45720,330 2.2%   
Gross profit Rs m-1616,748 -2.4%  
Depreciation Rs m21,826 0.1%   
Interest Rs m71848 8.3%   
Profit before tax Rs m-2234,312 -5.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-56342 -16.5%   
Profit after tax Rs m-1663,971 -4.2%  
Gross profit margin %-36.033.6 -107.2%  
Effective tax rate %25.37.9 318.9%   
Net profit margin %-37.319.8 -188.7%  
BALANCE SHEET DATA
Current assets Rs m35823,790 1.5%   
Current liabilities Rs m94026,090 3.6%   
Net working cap to sales %-130.6-11.4 1,140.4%  
Current ratio x0.40.9 41.8%  
Inventory Days Days8517 507.7%  
Debtors Days Days1,13577 1,480.9%  
Net fixed assets Rs m1,26244,398 2.8%   
Share capital Rs m432136 317.4%   
"Free" reserves Rs m45025,675 1.8%   
Net worth Rs m88225,811 3.4%   
Long term debt Rs m06,545 0.0%   
Total assets Rs m1,62068,188 2.4%  
Interest coverage x-2.26.1 -35.4%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.30.3 93.5%   
Return on assets %-5.97.1 -83.7%  
Return on equity %-18.915.4 -122.6%  
Return on capital %-17.215.9 -108.1%  
Exports to sales %00-   
Imports to sales %14.50.1 12,650.1%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m6523 280.9%   
Fx inflow Rs m00-   
Fx outflow Rs m6523 280.9%   
Net fx Rs m-65-23 280.9%   
CASH FLOW
From Operations Rs m1094,860 2.2%  
From Investments Rs m5-18,545 -0.0%  
From Financial Activity Rs m-14713,798 -1.1%  
Net Cashflow Rs m-34382 -8.8%  

Share Holding

Indian Promoters % 59.3 54.9 108.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 26.6 -  
FIIs % 0.0 8.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 40.8 45.1 90.3%  
Shareholders   35,313 46,346 76.2%  
Pledged promoter(s) holding % 0.0 18.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BH.IMMUN&BIO With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BH.IMMUN&BIO vs ERIS LIFESCIENCES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BH.IMMUN&BIO vs ERIS LIFESCIENCES Share Price Performance

Period BH.IMMUN&BIO ERIS LIFESCIENCES S&P BSE HEALTHCARE
1-Day 2.43% 0.75% 1.23%
1-Month -8.41% 7.84% -0.24%
1-Year -5.63% 45.26% 43.62%
3-Year CAGR -21.40% 22.75% 20.35%
5-Year CAGR 24.39% 27.14% 26.24%

* Compound Annual Growth Rate

Here are more details on the BH.IMMUN&BIO share price and the ERIS LIFESCIENCES share price.

Moving on to shareholding structures...

The promoters of BH.IMMUN&BIO hold a 59.3% stake in the company. In case of ERIS LIFESCIENCES the stake stands at 54.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BH.IMMUN&BIO and the shareholding pattern of ERIS LIFESCIENCES.

Finally, a word on dividends...

In the most recent financial year, BH.IMMUN&BIO paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

ERIS LIFESCIENCES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of BH.IMMUN&BIO, and the dividend history of ERIS LIFESCIENCES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.